콘텐츠로 건너뛰기
Merck
  • Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.

Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.

Lancet (London, England) (1980-03-22)
A P Ball, A M Geddes, P G Davey, I D Farrell, G R Brookes
초록

Clavulanic acid is an inhibitor of certain beta-lactamases, notably those enzymes which inactivate the penicillins and cause resistance of important bacteria to these antibiotics. Microbiological, pharmacological, and clinical studies show that clavulanic acid in combination with amoxycillin is effective and safe in the treatment of urinary-tract infection caused by amoxycillin-resistant bacteria.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Amoxicillin trihydrate: potassium clavulanate (4:1)